Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells. (2018)

First Author: Goundry A
Attributed to:  Proteolysis and life cycle progression in Leishmania funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1096/fj.201700797r

PubMed Identifier: 29097502

Publication URI: http://europepmc.org/abstract/MED/29097502

Type: Journal Article/Review

Volume: 32

Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Issue: 3

ISSN: 0892-6638